Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders

Current Opinion in Rheumatology

Volumn 21, Issue 1, 2009, Pages 78-84

  Goyal, Ramona ^a   Bulua, Ariel C ^d   Nikolov, Nikolay P ^b   Schwartzberg, Pamela L ^c   Siegel, Richard M ^d,e  

^a Office of the Director   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Autoimmunity; Immune regulation; Lymphopenia; Primary immunodeficiency disorders; Wiskott aldrich syndrome

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALOPECIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE THROMBOCYTOPENIA; AUTOIMMUNITY; B LYMPHOCYTE; CELL MATURATION; CHRONIC GRANULOMATOUS DISEASE; CHRONIC INFLAMMATION; COMMON VARIABLE IMMUNODEFICIENCY; COMPREHENSION; DERMATOMYOSITIS; DIABETES MELLITUS; ENTERITIS; ERYTHRODERMA; GLOMERULONEPHRITIS; GRANULOMA; HOMEOSTASIS; HUMAN; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; INTROSPECTION; IPEX SYNDROME; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE ADHESION DEFICIENCY; LIVER DYSFUNCTION; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOCYTOPENIA; NONHUMAN; OMENN SYNDROME; PATIENT CARE; PERNICIOUS ANEMIA; PHYSICIAN; POLYARTHRITIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; RHEUMATOLOGY; SEVERE COMBINED IMMUNODEFICIENCY; SPLENOMEGALY; THROMBOCYTOPENIA; UVEITIS; VASCULITIS; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEEDBACK; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC DEFICIENCY SYNDROMES; RHEUMATIC DISEASES; T-LYMPHOCYTES;

EID: 58149247985     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32831cb939     Document Type: Review

References (57)

1. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995; 333:431 -440.
2. Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004; 83:254-263.
3. Wang J, Cunningham-Rundles C. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005; 25:57-62.
4. Elhasid R, Bergman R, Etzioni A. Autoimmunity in severe combined immunodeficiency (SCID). Blood 2002; 100:2677-2678; author reply 2678-2679.
5. Milner JD, Fasth A, Etzioni A. Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models. J Clin Immunol 2008; 28 (Suppl 1):S29-S33.
6. Lee AH, Levinson Al, Schumacher HR Jr. Hypogammaglobulinemia and rheumatic disease. Semin Arthritis Rheum 1993; 22:252-264.
7. Uzel G, Kleiner DE, Kuhns DB, Holland SM. Dysfunctional LAD-1 neutrophils and colitis. Gastroenterology 2001; 121:958-964.
8. Arimura Y, Goto A, Yamashita K, et al. Intractable colitis associated with chronic granulomatous disease. J Med Microbiol 2006; 55:1587- 1590.
9. Honig M, Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol 2006; 18:383-388.
10. Surh CD, Sprent J. Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med 2000; 192:F9-F14.
11. Cabatingan MS, Schmidt MR, Sen R, Woodland RT. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol 2002; 169:6795-6805.
12. Min B, McHugh R, Sempowski GD, et al. Neonates support lymphopeniainduced proliferation. Immunity 2003; 18:131-140.
13. Goldrath AW, Sivakumar PV, Glaccum M, et al. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med 2002; 195:1515-1522.
14. Baccala R, Theofilopoulos AN. The new paradigm of T-cell homeostatic proliferation-induced autoimmunity. Trends Immunol 2005; 26:5-8.
15. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004; 117:265- 277.
16. Khiong K, Murakami M, Kitabayashi C, et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 2007; 117:1270-1281. Another link between lymphopenia and homeostatic expansion of T cells in a mouse model of Omenn syndrome.
17. Marrella V, Poliani PL, Casati A, et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 2007; 117:1260-1269.
18. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990; 322:1829-1836.
19. Liston A, Lesage S, Wilson J, et al. Aire regulates negative selection of organspecific T cells. Nat Immunol 2003; 4:350-354.
20. Ramsey C, Winqvist O, Puhakka L, et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11:397-409.
21. Anderson MS, Venanzi ES, Klein L, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395- 1401.
22. Cavadini P, Vermi W, Facchetti F, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005; 115:728-732.
23. Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR, Ochs HD. Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. J Clin Immunol 2008; 28 (Suppl 1):S11-S19.
24. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15:430-435.
25. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39:537-545.
26. Chang X, Zheng P, Liu Y. Homeostatic proliferation in the mice with germline • FoxP3 mutation and its contribution to fatal autoimmunity. J Immunol 2008; 181:2399-2406. An interesting paper implicating homeostatic proliferation in the genesis of autoimmunity in FoxP3 mutant mice.
27. Henriksson G, Manthorpe R, Bredberg A. Antibodies to CD4 in primary Sjogren's syndrome. Rheumatology (Oxford) 2000; 39:142-147.
28. Yamada A, Cohen PL, Winfield JB. Subset specificity of antilymphocyte antibodies in systemic lupus erythematosus: preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes. Arthritis Rheum 1985; 28:262-270.
29. Morimoto C, Reinherz EL, Distaso JA, et al. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest 1984; 73:689-700.
30. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper- IgM syndrome. J Pediatr 1997; 131:47-54.
31. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003; 82:373-384.
32. Arceci RJ. When T cells and macrophages do not talk: the hemophagocytic syndromes. Curr Opin Hematol 2008; 15:359-367.
33. Nichols KE, Ma CS, Cannons JL, et al. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005; 203:180-199.
34. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2- domain encoding gene. Nat Genet 1998; 20:129-135.
35. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829- 834.
36. Salzer U, Chapel HM, Webster AD, et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37:820-828.
37. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92:34-48.
38. Uluhan A, Sager D, Jasin HE. Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia. J Rheumatol 1998; 25:1205-1210.
39. Castigli E, Wilson SA, Scott S, et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005; 201:35-39.
40. Yan M, Wang H, Chan B, et al. Activation and accumulation of B cells in TACI- deficient mice. Nat Immunol 2001; 2:638-643.
41. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994; 125:876-885.
42. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 2003; 111 :e622-e627.
43. Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med 1999; 190:1329-1342.
44. Snapper SB, Meelu P, Nguyen D, et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 2005; 77:993-998.
45. Orange JS, Ramesh N, Remold-O'Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cellactivating immunologic synapses. Proc Natl Acad Sci U S A 2002; 99:11351-11356.
46. Pivniouk VI, Snapper SB, Kettner A, et al. Impaired signaling via the highaffinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells. Int Immunol 2003; 15:1431-1440.
47. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome proteindeficient mice reveal a role for WASP in T but not B cell activation. Immunity 1998; 9:81-91.
48. Humblet-Baron S, Sather B, AnoverS, et al. Wiskott-Aldrich syndrome protein is • required for regulatory T cell homeostasis. J Clin Invest 2007; 117:407-418. The paper implicates defective Treg homeostasis and function to the autoimmunity seen in the Wiskott-Aldrich syndrome.
49. Adriani M, Aoki J, Horai R, et al. Impaired in vitro regulatory T cell function • associated with Wiskott-Aldrich syndrome. Clin Immunol 2007; 124:41 -48. The paper implicates defective Treg homeostasis and function to the autoimmunity seen in the Wiskott-Aldrich syndrome.
50. Maillard MH, Cotta-de-Almeida V, Takeshima F, et al. The Wiskott-Aldrich • syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 2007; 204:381 -391. The paper implicates defective Treg homeostasis and function to the autoimmunity seen in the Wiskott-Aldrich syndrome.
51. Lorenzi R, Brickell PM, Katz DR, et al. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 2000; 95:2943- 2946.
52. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 1986; 322:32-38.
53. Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000; 79:155-169.
54. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189.
55. Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol 2003; 15:578-584.
56. Pollock JD, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9:202-209.
57. Kobayashi SD, Voyich JM, Braughton KR, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 2004; 172:636-643.